Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Acute Myeloid Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableAvailableNCT05593185
What this trial is testing

Expanded Access Program (EAP) for Galinpepimut-S (GPS) in Patients Diagnosed With AML or MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Sellas Life Sciences Group
Early research (Phase 1)Study completedNCT00070538
What this trial is testing

VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Vion Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT00720850
What this trial is testing

Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Who this might be right for
Myelodysplastic SyndromesAcute Myelogenous Leukemia
Technische Universität Dresden 10
Early research (Phase 1)Temporarily pausedNCT06514261
What this trial is testing

Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML

Who this might be right for
Acute Myeloid Leukemia
National Cancer Institute (NCI) 45
Early research (Phase 1)WithdrawnNCT05519527
What this trial is testing

STI-6129 CD38 ADC for the Treatment of Patients With Relapsed or Refractory Systemic ALL Amyloidosis

Who this might be right for
Refractory T Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia (AML)
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT03922100
What this trial is testing

Study of NMS-03592088 in Patients With Relapsed or Refractory AML or CMML

Who this might be right for
Acute Myeloid Leukemia (AML)Chronic Myelomonocytic Leukemia (CMML)
Nerviano Medical Sciences 63
Not applicableStudy completedNCT02525250
What this trial is testing

Pilot Study Immunomonitoring Natural Killers Cells in Patients With Myeloid Malignancies Treated With Lenalidomide

Who this might be right for
Acute Myeloid Leukemia or Myelodysplasic Syndrome
Institut Paoli-Calmettes 14
Early research (Phase 1)WithdrawnNCT02528877
What this trial is testing

Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis

Who this might be right for
Acute Myeloid Leukemia in RemissionPrimary MyelofibrosisPrimary Myelofibrosis, Prefibrotic Stage+2 more
City of Hope Medical Center
Not applicableLooking for participantsNCT03439371
What this trial is testing

Micro-transplantation in Elderly Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Centre Hospitalier Universitaire de Saint Etienne 21
Testing effectiveness (Phase 2)Ended earlyNCT00863434
What this trial is testing

Clofarabine and Cytarabine in Treating Patients With Acute Myeloid Leukemia With Minimal Residual Disease

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)+4 more
University of Washington 2
Early research (Phase 1)Study completedNCT01396499
What this trial is testing

Study to Assess Safety, Tolerability and Preliminary Efficacy of BKM120, PI3K Kinase Inhibitor, With Advanced Leukemias

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 16
Large-scale testing (Phase 3)UnknownNCT04722952
What this trial is testing

PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine，Cytarabine, G-CSF for Refractory or Relapsed AML

Who this might be right for
ImmunotherapyRefractory LeukemiaRelapsed Adult AML+1 more
The First Affiliated Hospital of Soochow University 30
Testing effectiveness (Phase 2)Ended earlyNCT00818649
What this trial is testing

Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 16
Early research (Phase 1)Ended earlyNCT05223699
What this trial is testing

Study of MGTA-117 in Patients With Adult Acute Myeloid Leukemia (AML) and Myelodysplasia-Excess Blasts (MDS-EB)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplasia
Magenta Therapeutics, Inc. 22
Not applicableStudy completedNCT00060021
What this trial is testing

Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation

Who this might be right for
Cancer
National Cancer Institute (NCI)
Not applicableStudy completedNCT00964821
What this trial is testing

Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 459
Early research (Phase 1)Study completedNCT03298516
What this trial is testing

DCLL9718S in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or DCLL9718S in Combination With Azacitidine in Participants With Previously Untreated AML Unsuitable for Intensive Induction Chemotherapy

Who this might be right for
Leukemia, Myeloid, Acute
Genentech, Inc. 19
Very early researchUnknownNCT06541444
What this trial is testing

Safety and Efficacy of NK520 to Treat Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia
Base Therapeutics (Shanghai) Co., Ltd. 9
Testing effectiveness (Phase 2)Study completedNCT03761914
What this trial is testing

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

Who this might be right for
Acute Myelogenous LeukemiaOvarian CancerColorectal Cancer+2 more
Sellas Life Sciences Group 26
Not applicableLooking for participantsNCT05703126
What this trial is testing

Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML

Who this might be right for
Acute Myeloid Leukemia, AdultCardiotoxicityEndothelial Dysfunction
Samara State Medical University 100
Next Page